BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 1999
View Archived Issues
Abbott: Q1 1999 highlights
Read More
Genelabs and SmithKline Beecham share DARPA grant for drug development
Read More
GnRH pharmaccine reduces testosterone to castration levels
Read More
AVI confirms that classic approaches valid for testing antisense compound
Read More
Efficacy of IL-2 Gene Medicine is enhanced by combination with chemotherapeutic agent
Read More
News from FASEB: CT-3 is a potent and long-acting analgesic with good tolerability
Read More
Phytopharm reports preliminary phase IIa results for P-54 in osteoarthritis
Read More
Novavax estrogen cream completes phase II trial
Read More
Oxazolidinones useful for resistant Gram-positive infections
Read More
Abarelix depot is safe and effective in patients with endometriosis
Read More
Inhibitors of PTKs and T-cell activation/proliferation in development at BMS
Read More
Shiseido provides methods of promoting hair regrowth
Read More
Aminomethyl benzofuran-based compounds as potent and selective 5-HT1A receptor ligands
Read More
Novel cytotoxic agent from Nippon Steel with potential in inflammation and osteoporosis
Read More
Taro evaluates anticonvulsant barbiturate compounds in dog model
Read More
Merck identifies a nonpeptide, linearly minimized, centrally constrained gpIIb/IIIa antagonist
Read More
News from FASEB: novel factor Xa inhibitor presented by DuPont Pharmaceuticals
Read More
Fujisawa, Quark collaborate on genomics research in the area of stroke
Read More
Amoxil cleared for b.i.d. dosing in children
Read More
Immunization strategy effectively blocks the behavioral effects of cocaine in monkeys
Read More
TerraGen raises financing, changes name to reflect expanded capabilities
Read More
Progen's heparanase inhibitor prevents restenosis in experimental model
Read More
Nabi nicotine vaccine shows promise in preclinical studies
Read More
Monsanto responds to press publication of Celebrex adverse events
Read More
PNU-159548 undergoes phase I trials; preclinical results presented at AACR meeting
Read More
TP-508 promotes the wound-healing process via a novel mechanism
Read More
Promising phase I/II data for 81C6 pave the way for phase III trials in brain tumor patients
Read More
Favorable efficacy and safety profile of CEP-701 in PDAC
Read More
Extensive preclinical evaluation establishes potential of novel antitumor agent --CHS-828
Read More